Cargando…
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent responsible for the development of a new coronavirus disease (COVID-19), is a highly transmittable virus which, in just ten months, infected more than 40 million people in 214 countries worldwide. After inhalation, a...
Autores principales: | Harrell, Carl Randall, Jovicic, Biljana Popovska, Djonov, Valentin, Volarevic, Vladislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678745/ https://www.ncbi.nlm.nih.gov/pubmed/33274176 http://dx.doi.org/10.1155/2020/1939768 |
Ejemplares similares
-
Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2021) -
Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
por: Harrell, Carl Randall, et al.
Publicado: (2019) -
Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
por: Harrell, Carl Randall, et al.
Publicado: (2020) -
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma
por: Harrell, C. Randall, et al.
Publicado: (2019) -
Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
por: Harrell, Carl Randall, et al.
Publicado: (2021)